Paracentesis-induced circulatory dysfunction: are there albumin alternatives?
Abstract Background Ascites is one of the main complications of advanced liver cirrhosis. It is defined as a pathological accumulation if free fluid in the peritoneal cavity. Main body of the abstract Ascites is a sign of decompensation in patients with liver cirrhosis and is associated with decreas...
Ausführliche Beschreibung
Autor*in: |
Ayman Alsebaey [verfasserIn] Eman Rewisha [verfasserIn] Imam Waked [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2020 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Egyptian Liver Journal - SpringerOpen, 2019, 10(2020), 1, Seite 6 |
---|---|
Übergeordnetes Werk: |
volume:10 ; year:2020 ; number:1 ; pages:6 |
Links: |
---|
DOI / URN: |
10.1186/s43066-020-00047-7 |
---|
Katalog-ID: |
DOAJ038847949 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ038847949 | ||
003 | DE-627 | ||
005 | 20230502133646.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230227s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s43066-020-00047-7 |2 doi | |
035 | |a (DE-627)DOAJ038847949 | ||
035 | |a (DE-599)DOAJ45cbb9066cf046dba2bdcc8533fea707 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RD1-811 | |
050 | 0 | |a RC799-869 | |
100 | 0 | |a Ayman Alsebaey |e verfasserin |4 aut | |
245 | 1 | 0 | |a Paracentesis-induced circulatory dysfunction: are there albumin alternatives? |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Background Ascites is one of the main complications of advanced liver cirrhosis. It is defined as a pathological accumulation if free fluid in the peritoneal cavity. Main body of the abstract Ascites is a sign of decompensation in patients with liver cirrhosis and is associated with decreased survival. Ascites is associated with bad cosmetic figure and poor quality of life. Ascites is a predisposing factor for developing hydrothorax, hernias, diastolic dysfunction, spontaneous bacterial peritonitis, and renal impairment especially hepatorenal syndrome. The main treatment is salt restriction and diuretics. By the time the patient become non-responder and develop tense ascites, abdominal large volume paracentesis is the treatment of choice. Its advantages are rapid, cheap, and 1 day hospitalization. The main drawback is the development of paracentesis-induced circulatory dysfunction (PICD) if no volume expanding drugs are used. PICD is associated with dilutional hyponatremia, renal impairment, so it is considered the silent killer. Albumin infusion is the standard preventive measure but since costly to other alternatives such as colloids, vasoconstrictors or lowering the standard doses of the albumin was studied and is promising. Conclusions This review summarized the effectiveness of other alternative drugs. | ||
650 | 4 | |a Ascites | |
650 | 4 | |a Large volume paracentesis | |
650 | 4 | |a Albumin | |
650 | 4 | |a Paracentesis-induced circulatory dysfunction | |
653 | 0 | |a Surgery | |
653 | 0 | |a Diseases of the digestive system. Gastroenterology | |
700 | 0 | |a Eman Rewisha |e verfasserin |4 aut | |
700 | 0 | |a Imam Waked |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Egyptian Liver Journal |d SpringerOpen, 2019 |g 10(2020), 1, Seite 6 |w (DE-627)1733559663 |x 20906226 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2020 |g number:1 |g pages:6 |
856 | 4 | 0 | |u https://doi.org/10.1186/s43066-020-00047-7 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/45cbb9066cf046dba2bdcc8533fea707 |z kostenfrei |
856 | 4 | 0 | |u http://link.springer.com/article/10.1186/s43066-020-00047-7 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2090-6226 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 10 |j 2020 |e 1 |h 6 |
author_variant |
a a aa e r er i w iw |
---|---|
matchkey_str |
article:20906226:2020----::aaetssnuecruaoyyfntoaehra |
hierarchy_sort_str |
2020 |
callnumber-subject-code |
RD |
publishDate |
2020 |
allfields |
10.1186/s43066-020-00047-7 doi (DE-627)DOAJ038847949 (DE-599)DOAJ45cbb9066cf046dba2bdcc8533fea707 DE-627 ger DE-627 rakwb eng RD1-811 RC799-869 Ayman Alsebaey verfasserin aut Paracentesis-induced circulatory dysfunction: are there albumin alternatives? 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Background Ascites is one of the main complications of advanced liver cirrhosis. It is defined as a pathological accumulation if free fluid in the peritoneal cavity. Main body of the abstract Ascites is a sign of decompensation in patients with liver cirrhosis and is associated with decreased survival. Ascites is associated with bad cosmetic figure and poor quality of life. Ascites is a predisposing factor for developing hydrothorax, hernias, diastolic dysfunction, spontaneous bacterial peritonitis, and renal impairment especially hepatorenal syndrome. The main treatment is salt restriction and diuretics. By the time the patient become non-responder and develop tense ascites, abdominal large volume paracentesis is the treatment of choice. Its advantages are rapid, cheap, and 1 day hospitalization. The main drawback is the development of paracentesis-induced circulatory dysfunction (PICD) if no volume expanding drugs are used. PICD is associated with dilutional hyponatremia, renal impairment, so it is considered the silent killer. Albumin infusion is the standard preventive measure but since costly to other alternatives such as colloids, vasoconstrictors or lowering the standard doses of the albumin was studied and is promising. Conclusions This review summarized the effectiveness of other alternative drugs. Ascites Large volume paracentesis Albumin Paracentesis-induced circulatory dysfunction Surgery Diseases of the digestive system. Gastroenterology Eman Rewisha verfasserin aut Imam Waked verfasserin aut In Egyptian Liver Journal SpringerOpen, 2019 10(2020), 1, Seite 6 (DE-627)1733559663 20906226 nnns volume:10 year:2020 number:1 pages:6 https://doi.org/10.1186/s43066-020-00047-7 kostenfrei https://doaj.org/article/45cbb9066cf046dba2bdcc8533fea707 kostenfrei http://link.springer.com/article/10.1186/s43066-020-00047-7 kostenfrei https://doaj.org/toc/2090-6226 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 10 2020 1 6 |
spelling |
10.1186/s43066-020-00047-7 doi (DE-627)DOAJ038847949 (DE-599)DOAJ45cbb9066cf046dba2bdcc8533fea707 DE-627 ger DE-627 rakwb eng RD1-811 RC799-869 Ayman Alsebaey verfasserin aut Paracentesis-induced circulatory dysfunction: are there albumin alternatives? 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Background Ascites is one of the main complications of advanced liver cirrhosis. It is defined as a pathological accumulation if free fluid in the peritoneal cavity. Main body of the abstract Ascites is a sign of decompensation in patients with liver cirrhosis and is associated with decreased survival. Ascites is associated with bad cosmetic figure and poor quality of life. Ascites is a predisposing factor for developing hydrothorax, hernias, diastolic dysfunction, spontaneous bacterial peritonitis, and renal impairment especially hepatorenal syndrome. The main treatment is salt restriction and diuretics. By the time the patient become non-responder and develop tense ascites, abdominal large volume paracentesis is the treatment of choice. Its advantages are rapid, cheap, and 1 day hospitalization. The main drawback is the development of paracentesis-induced circulatory dysfunction (PICD) if no volume expanding drugs are used. PICD is associated with dilutional hyponatremia, renal impairment, so it is considered the silent killer. Albumin infusion is the standard preventive measure but since costly to other alternatives such as colloids, vasoconstrictors or lowering the standard doses of the albumin was studied and is promising. Conclusions This review summarized the effectiveness of other alternative drugs. Ascites Large volume paracentesis Albumin Paracentesis-induced circulatory dysfunction Surgery Diseases of the digestive system. Gastroenterology Eman Rewisha verfasserin aut Imam Waked verfasserin aut In Egyptian Liver Journal SpringerOpen, 2019 10(2020), 1, Seite 6 (DE-627)1733559663 20906226 nnns volume:10 year:2020 number:1 pages:6 https://doi.org/10.1186/s43066-020-00047-7 kostenfrei https://doaj.org/article/45cbb9066cf046dba2bdcc8533fea707 kostenfrei http://link.springer.com/article/10.1186/s43066-020-00047-7 kostenfrei https://doaj.org/toc/2090-6226 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 10 2020 1 6 |
allfields_unstemmed |
10.1186/s43066-020-00047-7 doi (DE-627)DOAJ038847949 (DE-599)DOAJ45cbb9066cf046dba2bdcc8533fea707 DE-627 ger DE-627 rakwb eng RD1-811 RC799-869 Ayman Alsebaey verfasserin aut Paracentesis-induced circulatory dysfunction: are there albumin alternatives? 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Background Ascites is one of the main complications of advanced liver cirrhosis. It is defined as a pathological accumulation if free fluid in the peritoneal cavity. Main body of the abstract Ascites is a sign of decompensation in patients with liver cirrhosis and is associated with decreased survival. Ascites is associated with bad cosmetic figure and poor quality of life. Ascites is a predisposing factor for developing hydrothorax, hernias, diastolic dysfunction, spontaneous bacterial peritonitis, and renal impairment especially hepatorenal syndrome. The main treatment is salt restriction and diuretics. By the time the patient become non-responder and develop tense ascites, abdominal large volume paracentesis is the treatment of choice. Its advantages are rapid, cheap, and 1 day hospitalization. The main drawback is the development of paracentesis-induced circulatory dysfunction (PICD) if no volume expanding drugs are used. PICD is associated with dilutional hyponatremia, renal impairment, so it is considered the silent killer. Albumin infusion is the standard preventive measure but since costly to other alternatives such as colloids, vasoconstrictors or lowering the standard doses of the albumin was studied and is promising. Conclusions This review summarized the effectiveness of other alternative drugs. Ascites Large volume paracentesis Albumin Paracentesis-induced circulatory dysfunction Surgery Diseases of the digestive system. Gastroenterology Eman Rewisha verfasserin aut Imam Waked verfasserin aut In Egyptian Liver Journal SpringerOpen, 2019 10(2020), 1, Seite 6 (DE-627)1733559663 20906226 nnns volume:10 year:2020 number:1 pages:6 https://doi.org/10.1186/s43066-020-00047-7 kostenfrei https://doaj.org/article/45cbb9066cf046dba2bdcc8533fea707 kostenfrei http://link.springer.com/article/10.1186/s43066-020-00047-7 kostenfrei https://doaj.org/toc/2090-6226 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 10 2020 1 6 |
allfieldsGer |
10.1186/s43066-020-00047-7 doi (DE-627)DOAJ038847949 (DE-599)DOAJ45cbb9066cf046dba2bdcc8533fea707 DE-627 ger DE-627 rakwb eng RD1-811 RC799-869 Ayman Alsebaey verfasserin aut Paracentesis-induced circulatory dysfunction: are there albumin alternatives? 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Background Ascites is one of the main complications of advanced liver cirrhosis. It is defined as a pathological accumulation if free fluid in the peritoneal cavity. Main body of the abstract Ascites is a sign of decompensation in patients with liver cirrhosis and is associated with decreased survival. Ascites is associated with bad cosmetic figure and poor quality of life. Ascites is a predisposing factor for developing hydrothorax, hernias, diastolic dysfunction, spontaneous bacterial peritonitis, and renal impairment especially hepatorenal syndrome. The main treatment is salt restriction and diuretics. By the time the patient become non-responder and develop tense ascites, abdominal large volume paracentesis is the treatment of choice. Its advantages are rapid, cheap, and 1 day hospitalization. The main drawback is the development of paracentesis-induced circulatory dysfunction (PICD) if no volume expanding drugs are used. PICD is associated with dilutional hyponatremia, renal impairment, so it is considered the silent killer. Albumin infusion is the standard preventive measure but since costly to other alternatives such as colloids, vasoconstrictors or lowering the standard doses of the albumin was studied and is promising. Conclusions This review summarized the effectiveness of other alternative drugs. Ascites Large volume paracentesis Albumin Paracentesis-induced circulatory dysfunction Surgery Diseases of the digestive system. Gastroenterology Eman Rewisha verfasserin aut Imam Waked verfasserin aut In Egyptian Liver Journal SpringerOpen, 2019 10(2020), 1, Seite 6 (DE-627)1733559663 20906226 nnns volume:10 year:2020 number:1 pages:6 https://doi.org/10.1186/s43066-020-00047-7 kostenfrei https://doaj.org/article/45cbb9066cf046dba2bdcc8533fea707 kostenfrei http://link.springer.com/article/10.1186/s43066-020-00047-7 kostenfrei https://doaj.org/toc/2090-6226 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 10 2020 1 6 |
allfieldsSound |
10.1186/s43066-020-00047-7 doi (DE-627)DOAJ038847949 (DE-599)DOAJ45cbb9066cf046dba2bdcc8533fea707 DE-627 ger DE-627 rakwb eng RD1-811 RC799-869 Ayman Alsebaey verfasserin aut Paracentesis-induced circulatory dysfunction: are there albumin alternatives? 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Background Ascites is one of the main complications of advanced liver cirrhosis. It is defined as a pathological accumulation if free fluid in the peritoneal cavity. Main body of the abstract Ascites is a sign of decompensation in patients with liver cirrhosis and is associated with decreased survival. Ascites is associated with bad cosmetic figure and poor quality of life. Ascites is a predisposing factor for developing hydrothorax, hernias, diastolic dysfunction, spontaneous bacterial peritonitis, and renal impairment especially hepatorenal syndrome. The main treatment is salt restriction and diuretics. By the time the patient become non-responder and develop tense ascites, abdominal large volume paracentesis is the treatment of choice. Its advantages are rapid, cheap, and 1 day hospitalization. The main drawback is the development of paracentesis-induced circulatory dysfunction (PICD) if no volume expanding drugs are used. PICD is associated with dilutional hyponatremia, renal impairment, so it is considered the silent killer. Albumin infusion is the standard preventive measure but since costly to other alternatives such as colloids, vasoconstrictors or lowering the standard doses of the albumin was studied and is promising. Conclusions This review summarized the effectiveness of other alternative drugs. Ascites Large volume paracentesis Albumin Paracentesis-induced circulatory dysfunction Surgery Diseases of the digestive system. Gastroenterology Eman Rewisha verfasserin aut Imam Waked verfasserin aut In Egyptian Liver Journal SpringerOpen, 2019 10(2020), 1, Seite 6 (DE-627)1733559663 20906226 nnns volume:10 year:2020 number:1 pages:6 https://doi.org/10.1186/s43066-020-00047-7 kostenfrei https://doaj.org/article/45cbb9066cf046dba2bdcc8533fea707 kostenfrei http://link.springer.com/article/10.1186/s43066-020-00047-7 kostenfrei https://doaj.org/toc/2090-6226 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA AR 10 2020 1 6 |
language |
English |
source |
In Egyptian Liver Journal 10(2020), 1, Seite 6 volume:10 year:2020 number:1 pages:6 |
sourceStr |
In Egyptian Liver Journal 10(2020), 1, Seite 6 volume:10 year:2020 number:1 pages:6 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Ascites Large volume paracentesis Albumin Paracentesis-induced circulatory dysfunction Surgery Diseases of the digestive system. Gastroenterology |
isfreeaccess_bool |
true |
container_title |
Egyptian Liver Journal |
authorswithroles_txt_mv |
Ayman Alsebaey @@aut@@ Eman Rewisha @@aut@@ Imam Waked @@aut@@ |
publishDateDaySort_date |
2020-01-01T00:00:00Z |
hierarchy_top_id |
1733559663 |
id |
DOAJ038847949 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ038847949</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502133646.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/s43066-020-00047-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ038847949</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ45cbb9066cf046dba2bdcc8533fea707</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RD1-811</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC799-869</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Ayman Alsebaey</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Paracentesis-induced circulatory dysfunction: are there albumin alternatives?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Background Ascites is one of the main complications of advanced liver cirrhosis. It is defined as a pathological accumulation if free fluid in the peritoneal cavity. Main body of the abstract Ascites is a sign of decompensation in patients with liver cirrhosis and is associated with decreased survival. Ascites is associated with bad cosmetic figure and poor quality of life. Ascites is a predisposing factor for developing hydrothorax, hernias, diastolic dysfunction, spontaneous bacterial peritonitis, and renal impairment especially hepatorenal syndrome. The main treatment is salt restriction and diuretics. By the time the patient become non-responder and develop tense ascites, abdominal large volume paracentesis is the treatment of choice. Its advantages are rapid, cheap, and 1 day hospitalization. The main drawback is the development of paracentesis-induced circulatory dysfunction (PICD) if no volume expanding drugs are used. PICD is associated with dilutional hyponatremia, renal impairment, so it is considered the silent killer. Albumin infusion is the standard preventive measure but since costly to other alternatives such as colloids, vasoconstrictors or lowering the standard doses of the albumin was studied and is promising. Conclusions This review summarized the effectiveness of other alternative drugs.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ascites</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Large volume paracentesis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Albumin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Paracentesis-induced circulatory dysfunction</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Surgery</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the digestive system. Gastroenterology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Eman Rewisha</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Imam Waked</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Egyptian Liver Journal</subfield><subfield code="d">SpringerOpen, 2019</subfield><subfield code="g">10(2020), 1, Seite 6</subfield><subfield code="w">(DE-627)1733559663</subfield><subfield code="x">20906226</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1186/s43066-020-00047-7</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/45cbb9066cf046dba2bdcc8533fea707</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://link.springer.com/article/10.1186/s43066-020-00047-7</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2090-6226</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2020</subfield><subfield code="e">1</subfield><subfield code="h">6</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Ayman Alsebaey |
spellingShingle |
Ayman Alsebaey misc RD1-811 misc RC799-869 misc Ascites misc Large volume paracentesis misc Albumin misc Paracentesis-induced circulatory dysfunction misc Surgery misc Diseases of the digestive system. Gastroenterology Paracentesis-induced circulatory dysfunction: are there albumin alternatives? |
authorStr |
Ayman Alsebaey |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)1733559663 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RD1-811 |
illustrated |
Not Illustrated |
issn |
20906226 |
topic_title |
RD1-811 RC799-869 Paracentesis-induced circulatory dysfunction: are there albumin alternatives? Ascites Large volume paracentesis Albumin Paracentesis-induced circulatory dysfunction |
topic |
misc RD1-811 misc RC799-869 misc Ascites misc Large volume paracentesis misc Albumin misc Paracentesis-induced circulatory dysfunction misc Surgery misc Diseases of the digestive system. Gastroenterology |
topic_unstemmed |
misc RD1-811 misc RC799-869 misc Ascites misc Large volume paracentesis misc Albumin misc Paracentesis-induced circulatory dysfunction misc Surgery misc Diseases of the digestive system. Gastroenterology |
topic_browse |
misc RD1-811 misc RC799-869 misc Ascites misc Large volume paracentesis misc Albumin misc Paracentesis-induced circulatory dysfunction misc Surgery misc Diseases of the digestive system. Gastroenterology |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Egyptian Liver Journal |
hierarchy_parent_id |
1733559663 |
hierarchy_top_title |
Egyptian Liver Journal |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)1733559663 |
title |
Paracentesis-induced circulatory dysfunction: are there albumin alternatives? |
ctrlnum |
(DE-627)DOAJ038847949 (DE-599)DOAJ45cbb9066cf046dba2bdcc8533fea707 |
title_full |
Paracentesis-induced circulatory dysfunction: are there albumin alternatives? |
author_sort |
Ayman Alsebaey |
journal |
Egyptian Liver Journal |
journalStr |
Egyptian Liver Journal |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2020 |
contenttype_str_mv |
txt |
container_start_page |
6 |
author_browse |
Ayman Alsebaey Eman Rewisha Imam Waked |
container_volume |
10 |
class |
RD1-811 RC799-869 |
format_se |
Elektronische Aufsätze |
author-letter |
Ayman Alsebaey |
doi_str_mv |
10.1186/s43066-020-00047-7 |
author2-role |
verfasserin |
title_sort |
paracentesis-induced circulatory dysfunction: are there albumin alternatives? |
callnumber |
RD1-811 |
title_auth |
Paracentesis-induced circulatory dysfunction: are there albumin alternatives? |
abstract |
Abstract Background Ascites is one of the main complications of advanced liver cirrhosis. It is defined as a pathological accumulation if free fluid in the peritoneal cavity. Main body of the abstract Ascites is a sign of decompensation in patients with liver cirrhosis and is associated with decreased survival. Ascites is associated with bad cosmetic figure and poor quality of life. Ascites is a predisposing factor for developing hydrothorax, hernias, diastolic dysfunction, spontaneous bacterial peritonitis, and renal impairment especially hepatorenal syndrome. The main treatment is salt restriction and diuretics. By the time the patient become non-responder and develop tense ascites, abdominal large volume paracentesis is the treatment of choice. Its advantages are rapid, cheap, and 1 day hospitalization. The main drawback is the development of paracentesis-induced circulatory dysfunction (PICD) if no volume expanding drugs are used. PICD is associated with dilutional hyponatremia, renal impairment, so it is considered the silent killer. Albumin infusion is the standard preventive measure but since costly to other alternatives such as colloids, vasoconstrictors or lowering the standard doses of the albumin was studied and is promising. Conclusions This review summarized the effectiveness of other alternative drugs. |
abstractGer |
Abstract Background Ascites is one of the main complications of advanced liver cirrhosis. It is defined as a pathological accumulation if free fluid in the peritoneal cavity. Main body of the abstract Ascites is a sign of decompensation in patients with liver cirrhosis and is associated with decreased survival. Ascites is associated with bad cosmetic figure and poor quality of life. Ascites is a predisposing factor for developing hydrothorax, hernias, diastolic dysfunction, spontaneous bacterial peritonitis, and renal impairment especially hepatorenal syndrome. The main treatment is salt restriction and diuretics. By the time the patient become non-responder and develop tense ascites, abdominal large volume paracentesis is the treatment of choice. Its advantages are rapid, cheap, and 1 day hospitalization. The main drawback is the development of paracentesis-induced circulatory dysfunction (PICD) if no volume expanding drugs are used. PICD is associated with dilutional hyponatremia, renal impairment, so it is considered the silent killer. Albumin infusion is the standard preventive measure but since costly to other alternatives such as colloids, vasoconstrictors or lowering the standard doses of the albumin was studied and is promising. Conclusions This review summarized the effectiveness of other alternative drugs. |
abstract_unstemmed |
Abstract Background Ascites is one of the main complications of advanced liver cirrhosis. It is defined as a pathological accumulation if free fluid in the peritoneal cavity. Main body of the abstract Ascites is a sign of decompensation in patients with liver cirrhosis and is associated with decreased survival. Ascites is associated with bad cosmetic figure and poor quality of life. Ascites is a predisposing factor for developing hydrothorax, hernias, diastolic dysfunction, spontaneous bacterial peritonitis, and renal impairment especially hepatorenal syndrome. The main treatment is salt restriction and diuretics. By the time the patient become non-responder and develop tense ascites, abdominal large volume paracentesis is the treatment of choice. Its advantages are rapid, cheap, and 1 day hospitalization. The main drawback is the development of paracentesis-induced circulatory dysfunction (PICD) if no volume expanding drugs are used. PICD is associated with dilutional hyponatremia, renal impairment, so it is considered the silent killer. Albumin infusion is the standard preventive measure but since costly to other alternatives such as colloids, vasoconstrictors or lowering the standard doses of the albumin was studied and is promising. Conclusions This review summarized the effectiveness of other alternative drugs. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA |
container_issue |
1 |
title_short |
Paracentesis-induced circulatory dysfunction: are there albumin alternatives? |
url |
https://doi.org/10.1186/s43066-020-00047-7 https://doaj.org/article/45cbb9066cf046dba2bdcc8533fea707 http://link.springer.com/article/10.1186/s43066-020-00047-7 https://doaj.org/toc/2090-6226 |
remote_bool |
true |
author2 |
Eman Rewisha Imam Waked |
author2Str |
Eman Rewisha Imam Waked |
ppnlink |
1733559663 |
callnumber-subject |
RD - Surgery |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.1186/s43066-020-00047-7 |
callnumber-a |
RD1-811 |
up_date |
2024-07-03T20:13:47.696Z |
_version_ |
1803590175503155200 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ038847949</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502133646.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/s43066-020-00047-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ038847949</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ45cbb9066cf046dba2bdcc8533fea707</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RD1-811</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC799-869</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Ayman Alsebaey</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Paracentesis-induced circulatory dysfunction: are there albumin alternatives?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Background Ascites is one of the main complications of advanced liver cirrhosis. It is defined as a pathological accumulation if free fluid in the peritoneal cavity. Main body of the abstract Ascites is a sign of decompensation in patients with liver cirrhosis and is associated with decreased survival. Ascites is associated with bad cosmetic figure and poor quality of life. Ascites is a predisposing factor for developing hydrothorax, hernias, diastolic dysfunction, spontaneous bacterial peritonitis, and renal impairment especially hepatorenal syndrome. The main treatment is salt restriction and diuretics. By the time the patient become non-responder and develop tense ascites, abdominal large volume paracentesis is the treatment of choice. Its advantages are rapid, cheap, and 1 day hospitalization. The main drawback is the development of paracentesis-induced circulatory dysfunction (PICD) if no volume expanding drugs are used. PICD is associated with dilutional hyponatremia, renal impairment, so it is considered the silent killer. Albumin infusion is the standard preventive measure but since costly to other alternatives such as colloids, vasoconstrictors or lowering the standard doses of the albumin was studied and is promising. Conclusions This review summarized the effectiveness of other alternative drugs.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ascites</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Large volume paracentesis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Albumin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Paracentesis-induced circulatory dysfunction</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Surgery</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the digestive system. Gastroenterology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Eman Rewisha</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Imam Waked</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Egyptian Liver Journal</subfield><subfield code="d">SpringerOpen, 2019</subfield><subfield code="g">10(2020), 1, Seite 6</subfield><subfield code="w">(DE-627)1733559663</subfield><subfield code="x">20906226</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1186/s43066-020-00047-7</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/45cbb9066cf046dba2bdcc8533fea707</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://link.springer.com/article/10.1186/s43066-020-00047-7</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2090-6226</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2020</subfield><subfield code="e">1</subfield><subfield code="h">6</subfield></datafield></record></collection>
|
score |
7.400629 |